SRF and hepatocellular carcinoma: For instance, the TRPM7 channel, a known upstream inducer of this pathway, can be pharmacologically targeted using small-molecule inhibitors NS8593 and its improved structural derivatives, which we established as potent suppressors of SRF activity and HCC cell proliferation [6].